Factsheet data is now cached locally - if you have visited a page you can now view it offline!
Are you a harm reduction organisation using TripSit? Let us know about you!
4-MeO-PCP
Basic Information
Summary
An arylcyclohexamine dissociative anaesthetic related to PCP. First discovered in the 1960s by Parke-Davis, it was introduced to the RC market in 2008. Reported to be less potent than PCP. It is not commonly seen, but has seen some increase in popularity with the inavailability of other dissociatives.
Dissociative
Dissociatives are mostly NMDA receptor antagonists, these substances are hallucinogenic but different than psychedelics. As per the name, these substances create a distance between the user and reality.
Read more on TripSit Wiki...Research Chemical
Research chemicals are drugs with relatively little history of human use, and thus particular care should be taken if choosing to ingest them.
Read more on TripSit Wiki...Habit-forming
These drugs pose a higher risk of causing habit forming behaviour, take particular care with the amount and frequency they are taken.
Read more on TripSit Wiki...Dose
Oral | |
---|---|
Threshold | 25-50mg |
Light | 50-100mg |
Common | 100-150mg |
Strong | 150mg+ |
NOTE: These doses are tentative and may need further research.
Duration
All ROAs | |
---|---|
Onset | 45-90 minutes |
Duration | 8-15 hours |
After-effects | 1-24 hours |
Aliases
4meopcp
Interactions
No interaction information for 4-MeO-PCP